News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
80 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17578)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
1 (227)
2 (108)
4 (1)
5 (130)
6 (164)
7 (194)
8 (175)
9 (134)
12 (127)
13 (143)
14 (122)
15 (126)
16 (80)
19 (104)
20 (129)
21 (109)
22 (127)
23 (72)
26 (111)
27 (121)
28 (135)
29 (106)
30 (90)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
FDA
Alcon Canada Receives Approval for JETREA™ (Ocriplasmin) Solution for Intravitreal Injection, the First and Only Eye Medicine to Treat Sight-Threatening, Symptomatic Vitreomacular Adhesion
August 16, 2013
·
6 min read
Drug Development
Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
August 16, 2013
·
5 min read
Deals
Ophthotech Corporation Eyes $85 Million IPO, Sets Sight on Late-Stage Clinical Trial
August 16, 2013
·
1 min read
Drug Development
Eli Lilly and Company Linagliptin Demonstrated Significant HbA1c Reduction in Elderly People With Type 2 Diabetes With Inadequate Glycemic Control
August 16, 2013
·
11 min read
CircuLite Warns on Synergy Heart Pumps After Receiving Cannula Fracture Reports
August 16, 2013
·
1 min read
Menarini Group’s Glucose Testing Strips Recalled Over False Reading Worry
August 16, 2013
·
1 min read
Pharm Country
Pretreating Aggressive Lymphoma With Targeted Therapy Improves Chemotherapy Effectiveness, Weill Cornell Medical College Study
August 16, 2013
·
9 min read
Business
Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for Second Quarter 2013 – Results From 1 January to 30 June, 2013
August 16, 2013
·
1 min read
Business
NuVasive, Inc. Announces Expansion and Relocation of UK Office
August 16, 2013
·
4 min read
Biotech Bay
InSite Vision Announces Patent Issuance on DuraSite® 2 Ophthalmic Drug Delivery System
August 16, 2013
·
1 min read
Previous
6 of 8
Next